Noticias de HIMS_US
Noticias del mercado
Últimas noticias sobre HIMS_US — 916 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Explore los pronósticos de acciones de Hims & Hers Health de terceros, con análisis técnico, sentimiento de CFD, historial de precios de HIMS y vista de analista de Capital.com. El 79,75% de los inversores pierde dinero.
Michigan-based investment advisor Cedar Grove Capital Management recently released its third-quarter 2026 investor letter. The letter can be downloaded here. In Q3 2026, Cedar Grove Capital Management’s Multi-Strategy Composite returned -12.7%, trailing the Russell 2000 (-7.2%), Russell Microcap (-7.4%), and S&P 500 (+2.4%). Since its January 14, 2026, inception, the composite has returned -26.2%, compared […]
Hims & Hers Health, Inc. Securities Fraud Class Action
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn…
/PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit...
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized
Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims & Hers Health, Inc. (NYSE: HIMS) What:...
NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / October 5, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.
Página 10 de 46